Human pancreatic cancer cells expressing mutated BRCA2 lead to hypersensitivity from MMS treatment (Chen et al., 1998) and hsbrca2 mutant embryos are also hypersensitive to γ-irradiation (Sharan et al., 1997). The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.